olaparib
astrazeneca,merck
['vance', 'olaparib', 'thanks', 'solo-1', 'brca', 'ovarian']
solo-1 7 year overall survival analysis-clinically meaningful improved os with 2 years maintenance olaparib for women with newly diagnosed advanced brcam ovarian cancer. thanks to patients and research teams #esmo2022 
Consultant Medical Oncologist, Royal Marsden, Team Leader ICR All views my own